Shareholders on the South African register of the Company are referred to MediclinicĂs announcement of the interim results for the six months ended 30 September 2017 and the declaration of dividend released on the Stock Exchange News Service and on the Regulatory News Service on 16 November 2017, confirming that the Board of Directors of Mediclinic had approved an interim dividend from retained earnings of 3.20 pence per ordinary share for the six months ended 30 September 2017.
The interim dividend will be paid on Monday, 18 December 2017 to all ordinary shareholders who are on the register of members at the close of business on the record date of Friday, 8 December 2017.
Shareholders on the South African register will be paid the ZAR cash equivalent of 59.87200 cents (47.89760 cents net of dividend withholding tax) per share. A dividend withholding tax of 20% will be applicable to all shareholders on the South African register who are not exempt therefrom. The ZAR cash equivalent has been calculated using the following exchange rate: GBP1: ZAR18.71, being the five-day average ZAR/GBP exchange rate (Bloomberg) on Friday, 10 November 2017 at 3:00pm GMT.